GINA SMITH: Open Payments
NPI 1750803284 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,263 in 128 payments from 22 companies in 2025. Trend: 2023 $1,363 · 2024 $1,711 · 2025 $2,263
Food & beverage: $2,263
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $428 |
| AstraZeneca Pharmaceuticals LP | 10 | $231 |
| Axsome Therapeutics, Inc. | 20 | $205 |
| Medline Industries LP | 1 | $183 |
| GlaxoSmithKline, LLC. | 10 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $148 |
| Otsuka America Pharmaceutical, Inc. | 6 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $75 |
| PFIZER INC. | 4 | $73 |
Products named: UBRELVY, Auvelity, AIRSUPRA, TRELEGY ELLIPTA, CAPLYTA, VRAYLAR, JARDIANCE, REXULTI.
Industry payments across KY — which companies pay providers there.
